Haemonetics Corp (HAE)

R&D Expense Growth

12.14%

Quarterly · Period ending:

HAE logo

HAE R&D Expense Growth

Latest reported12.14%
HAE Quarterly R&D Growth (QoQ) (0.00% → 12.14%)
High-resolution chart · PNG

HAE r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Haemonetics Corp R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-13.3479%
5.6687%
23.8458%
1.6449%
10.9203%
-1.9211%
0%
5.5556%
-12.1951%
5.1282%
18.1818%
-13.1579%
0%
-11.6279%
-8.5106%
-6%
6.383%
2.1739%
-2.1277%
-6%
4.1667%
-2.0408%
8.8889%
4.6512%
4.878%
0%
-2.381%
-2.3256%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.